According to the research report titled ‘Global Electrophoresis Reagents Market Size study, By Products (Dyes, Gels, Buffers, Other Reagents), By Techniques (Gel Electrophoresis, Capillary Electrophoresis), By Application (Protein Analysis, DNA & RNA Analysis), By End User (Academic & Research Institutions, Pharmaceutical & Biotech Companies, Hospitals & Diagnostic Centers, Other End Users), and Regional Forecasts 2022-2028’, available with MarketStudyReport, global electrophoresis reagents market was worth USD 1.11 billion in 2021 and is anticipated to expand at 5.4% CAGR during the forecast period to be worth USD 1.60 billion by the year 2028.

Report findings suggest that rising incidence of cancer, genetic abnormalities, infectious diseases, in consort with technological improvements, ever-increasing elderly population, and growing availability of funding for genomic as well as proteomic research are the major growth determinants for global electrophoresis reagents market.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/5065448/

For the unversed, electrophoresis is a method to separating and differentiating macromolecules like DNA and RNA from the sample based on their charge and size. It is widely used in pharmaceutical field for diagnostics and research purposes.  

Furthermore, rising demand for personalized medicine, and the shifting preference from plant-derived to genome-based drug discovery are expected to bolster industry outlook in the coming years.

However, ongoing safety concerns about time-consuming operations and mutagenic nucleic acid dyes, along with limited sample analysis using gel electrophoresis may stifle market growth over the stipulated timeframe.

Speaking of techniques, worldwide electrophoresis reagents industry is classified into capillary electrophoresis, and gel electrophoresis. The different products include buffers, gels, dyes, and others. While application spectrum is categorized into DNA & RNA analysis, and protein analysis. Various end-users are hospitals & diagnostic centers, pharmaceutical & biotech companies, academic & research institutions, and others.

Regionally, North America market holds major revenue share at present, owing to early adoption of new diagnostics technology, accessibility to cutting-edge healthcare facilities, and rising investments in proteomic & genomic research in the region.

Whereas Asia Pacific industry is poised to progress with a healthy CAGR over the forecast timeframe, due to rising elderly population, and increasing prevalence of target diseases in the region.

Harvard Bioscience, Inc., Takara Bio, Inc., Agilent Technologies, Inc., GE Healthcare, Merck Millipore, Qiagen N.V., Bio-Rad Laboratories, Inc., Sigma-Aldrich Corporation, Lonza Group AG, and Thermo Fisher Scientific, Inc. are the prominent players in global electrophoresis reagents market.